PROPHYLAKTISCHER ODER THERAPEUTISCHER WIRKSTOFF GEGEN GRIPPEVIRUSINFEKTION

European patent · EP2875813 · In force

Register entry

Publication number
EP2875813
Application number
EP13819512
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 3, 2013
Published
May 27, 2015
Granted
Apr 18, 2018
Protection ends at the latest
Jun 2, 2033
Next annual fee due
Jun 30, 2026
IPC classes
A61K 31/197 (2006.01)
A61K 33/26 (2006.01)
A61P 31/16 (2006.01)
A61P 43/00 (2006.01)
Priority
JP 2012160999 19.07.2012
PCT application
PCT/JP2013/003486 03.06.2013
PCT publication
WO2014/013664 23.01.2014
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2025

    Change

    Published in Swissreg on 01.07.2025

  2. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  3. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  4. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  5. Apr 18, 2018

    Granted

    Published in Swissreg on 18.04.2018

Parties

Holder

SBI Pharmaceuticals Co., Ltd.

6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, JP

Tokushima University

24, Shinkura-cho 2-chome Tokushima-shi, Tokushima 770-8501, JP

Inventor

TANAKA, Tohru

Tokyo 106-6020, JP

NAKAJIMA, Motowo

Tokyo 106-6020, JP

TAKAHASHI, Kiwamu

Tokyo 106-6020, JP

ISHII, Takuya

Tokyo 106-6020, JP

KIDO, Hiroshi

Tokushima-shi Tokushima 770-8503, JP

CHIDA, Junji

Tokushima-shi Tokushima 770-8503, JP

YAMANE, Kazuhiko

Tokushima-shi Tokushima 770-8503, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.